These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9618412)

  • 21. Clofibric acid, phenylpyruvate, and dichloroacetate inhibition of branched-chain alpha-ketoacid dehydrogenase kinase in vitro and in perfused rat heart.
    Paxton R; Harris RA
    Arch Biochem Biophys; 1984 May; 231(1):58-66. PubMed ID: 6721502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
    Amacher DE; Beck R; Schomaker SJ; Kenny CV
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of hypolipidemic drugs gemfibrozil, ciprofibrate, and clofibric acid on peroxisomal beta-oxidation in primary cultures of rainbow trout hepatocytes.
    Donohue M; Baldwin LA; Leonard DA; Kostecki PT; Calabrese EJ
    Ecotoxicol Environ Saf; 1993 Oct; 26(2):127-32. PubMed ID: 7504609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A comparison of bezafibrate and clofibrate in type II B and type IV hyperlipoproteinemia].
    Bolzano K; Krempler F; Schellenberg B; Schlierf G
    Acta Med Austriaca; 1979; 6(3):90-4. PubMed ID: 547652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of dihydrodiol dehydrogenase in rat H-4IIe hepatoma cells.
    Buller AL; Sharp RB; Penning TM
    Cancer Res; 1989 Dec; 49(24 Pt 1):6976-80. PubMed ID: 2684404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute and chronic effects of clofibrate and clofibric acid on the enzymes acetylcholinesterase, lactate dehydrogenase and catalase of the mosquitofish, Gambusia holbrooki.
    Nunes B; Carvalho F; Guilhermino L
    Chemosphere; 2004 Dec; 57(11):1581-9. PubMed ID: 15519403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A clofibric acid derivative with hypolipemic and platelet antiaggregant action].
    Dănilă G; Nechifor M; Filip M; Păduraru I; Ifrim C; Grădinariu D; Papa V; Manolescu A; Bădescu A
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):127-32. PubMed ID: 3393745
    [No Abstract]   [Full Text] [Related]  

  • 28. Stimulation of rat liver branched-chain alpha-keto acid dehydrogenase activity by low doses of bezafibrate.
    Knapik-Czajka M
    Toxicology; 2013 Apr; 306():101-7. PubMed ID: 23485652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential induction profile of drug-metabolizing enzymes after treatment with hypolipidaemic agents.
    Fournel S; Magdalou J; Pinon P; Siest G
    Xenobiotica; 1987 Apr; 17(4):445-57. PubMed ID: 2885979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute muscular syndrome after bezafibrate.
    Bock KD
    Klin Wochenschr; 1981 Dec; 59(23):1321. PubMed ID: 7311399
    [No Abstract]   [Full Text] [Related]  

  • 31. [pH-dependence of hormone-binding and enzymatic activity of estrophilic hydroxysteroid dehydrogenase from the rabbit liver].
    Smirnov AN
    Biokhimiia; 1990 Jun; 55(6):1073-80. PubMed ID: 2207205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steady-state kinetics of bezafibrate and clofibrate in healthy female volunteers.
    Abshagen U; Spörl-Radun S; Marinow J
    Eur J Clin Pharmacol; 1980 Apr; 17(4):305-8. PubMed ID: 6995131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Separation of fibrate-type antihyperlipidemic drugs by capillary electrophoresis and their quantitation in pharmaceuticals.
    Komsta Ł; Misztal G; Majchrzak E; Hauzer A
    J Pharm Biomed Anal; 2006 May; 41(2):408-14. PubMed ID: 16426791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of prolonged clofibrate treatment on the plasma drug concentration and liver NADP-linked enzymes activity.
    Zelewski M; Swierczyński J
    Gen Pharmacol; 1986; 17(1):117-9. PubMed ID: 3949145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro evaluation of inhibitory effects of antidiabetic and antihyperlipidemic drugs on human carboxylesterase activities.
    Fukami T; Takahashi S; Nakagawa N; Maruichi T; Nakajima M; Yokoi T
    Drug Metab Dispos; 2010 Dec; 38(12):2173-8. PubMed ID: 20810539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of covalent binding to rat liver DNA of the hypolipidemic drugs clofibrate and fenofibrate.
    von Däniken A; Lutz WK; Schlatter C
    Toxicol Lett; 1981 Feb; 7(4-5):305-10. PubMed ID: 7222106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro metabolism of fenofibric acid by carbonyl reducing enzymes.
    Malátková P; Kanavi M; Nobilis M; Wsól V
    Chem Biol Interact; 2016 Oct; 258():153-8. PubMed ID: 27599626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fenofibrate but not fenofibric acid inhibits 11beta-hydroxysteroid dehydrogenase 1 in C2C12 myotubes.
    Kim CH; Ramu R; Ahn JH; Bae MA; Cho YS
    Mol Cell Biochem; 2010 Nov; 344(1-2):91-8. PubMed ID: 20614230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implication of fibrate therapy for homocysteine.
    Goffin E; Jamar F; Desager JP; Devuyst O
    Lancet; 1999 Oct; 354(9185):1209. PubMed ID: 10513738
    [No Abstract]   [Full Text] [Related]  

  • 40. Decrease of superoxide dismutase and glutathione peroxidase in liver of rats treated with hypolipidemic drugs.
    Ciriolo MR; Mavelli I; Rotilio G; Borzatta V; Cristofari M; Stanzani L
    FEBS Lett; 1982 Aug; 144(2):264-8. PubMed ID: 7117540
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.